SightScore is a saliva test that looks at millions of genetic variants in the patient’s genome to create a personalized ...

AI has demonstrated remarkable proficiency in diagnosing various eye diseases, including diabetic retinopathy, glaucoma, and ...

Study was conducted by researchers at Department of Ophthalmology of ‘The Second Affiliated Hospital’ in Hefei-based Anhui ...

A randomized, controlled trial has shown that DSLT delivers effective intraocular pressure (IOP) control and has a strong safety profile with low risk of adverse events. 3* The data and early feedback ...

10 A randomized, controlled trial has shown that DSLT delivers effective intraocular pressure (IOP) control and has a strong safety profile with low risk of adverse events.3* The data and early ...

Revenio Group Corporation | Stock Exchange Release | February 21, 2025 at 16:00:00 EET The Board of Directors of Revenio Group Corporation has decided on a directed share issue without payment based o ...

Brent Saunders; Chairman of the Board, Chief Executive Officer; Bausch & Lomb Corp Sam Eldessouky; Chief Financial Officer, Executive Vice President; Bausch & Lomb Corp Thank you. Good morning, ...

A total of 4,180 of the company’s treasury shares will be transferred in a directed issue without payment to persons included in the restricted share plan RSP 2024-2026. A total of 400 of the ...

The lecture will consider factors such as disease severity, glaucoma type, and overall eye health. The speakers will also ...

Seonix Bio, a leader in the development of genetic testing for glaucoma, today announced the U.S. launch of SightScore, the ...